| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/11/2001 | CN1291199A Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production |
| 04/11/2001 | CN1291198A Three-dimesional structures and models of Fc receptors and use thereof |
| 04/11/2001 | CN1291106A Novel preventives/remedies for immunopathy |
| 04/11/2001 | CN1291096A Use of inhibitors for treatment of disorders related to RTK hyperfunction |
| 04/11/2001 | CN1290746A New nucleotide sequence of coded Irp gene |
| 04/10/2001 | US6215048 Nucleic acid sequences encoding an antifungal polypeptide, aly AFP from alyssum and methods for their use |
| 04/10/2001 | US6215045 Developmental regulation in anther tissue of plants |
| 04/10/2001 | US6215044 Nucleotide and amino acid sequence; for transgenic plants with altered phenotypes especially during ripening |
| 04/10/2001 | US6215043 Method for shortening internode of inflorescence by introducing gene for petunia transcription factor PetSPL2 |
| 04/10/2001 | US6215040 IL-5 transgenic mouse |
| 04/10/2001 | US6214985 Amino acid and nucleotide sequences; diagnosis, prevention, and treatment of autoimmune disorders; antidiabetic agents |
| 04/10/2001 | US6214983 Isolated nucleic acid molecules which encode SCP proteins |
| 04/10/2001 | US6214982 Ribonuclease resistant RNA preparation and utilization |
| 04/10/2001 | US6214981 Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof |
| 04/10/2001 | US6214975 Predicting yield of protein product of purification process by first using multiple batches of fermentation medium to determinine correlation between yield and quality based on western blot, then testing sample |
| 04/10/2001 | US6214974 Internalizable cell binding component having biotin binding element conjugated to biotinylated nucleic acids or cytotoxic moieties such as gelonin, ricin, saporin, abrin, diptheria toxin and the like; gene therapy; drug delivery of toxins |
| 04/10/2001 | US6214972 Human receptor of defined amino acid sequence; for recombinant preparation of membranes for screening agonists and antagonists; treatment of sleep disorders, allergic rhinitis, glaucoma, congestive heart failure; antiinflammatory agents |
| 04/10/2001 | US6214971 Compounds and methods for the diagnosis and treatment of Babesia microti infection |
| 04/10/2001 | US6214970 Hepatitis E virus antigens and uses therefor |
| 04/10/2001 | US6214968 Fibroblast stimulating growth factor 1 (FsF-1) and the early detection of fibrosis |
| 04/10/2001 | US6214804 Producing antibodies directed to protein of hiv virus in mice, dna plasmids |
| 04/10/2001 | US6214797 Binding corticotropin releasing factor receptor 2 with binding affinity, increased production of adrenocorticotropic hormone and peptide with amino acid sequences |
| 04/10/2001 | US6214796 Administering a polypeptide growth factor for improved sensor motor deficit caused by injury |
| 04/10/2001 | US6214795 Polypetides with amino acid sequences |
| 04/10/2001 | US6214794 Proliferation or differentiation of nonpost mitotic neuronal cells with polypeptides |
| 04/10/2001 | US6214790 Neo-tryptophan |
| 04/10/2001 | US6214615 Cloned genes for human dopamine D2 receptors and cell lines expressing same |
| 04/10/2001 | US6214614 Cell cycle regulated repressor and DNA element |
| 04/10/2001 | US6214606 Non-chromosomal dna which encodes the protein of defined amino acid sequence; for folding newly synthesized proteins into their biologically active conformation |
| 04/10/2001 | US6214602 Host cells for expression of clostridial toxins and proteins |
| 04/10/2001 | US6214600 Polypeptide of defined amino acid sequence; treatment of alzheimer's disease, stroke, musculoskeletal disease, heart disease, kidney disease; anticarcinogenic/antiinflammatory agents; antiarthritic agents; diagnosis |
| 04/10/2001 | US6214595 Enzymatic polypeptide for utilization in screening bactericides; wound healing agents; for prevent of bacterial wound infections |
| 04/10/2001 | US6214588 Polymerase holoenzyme; for use in design drugs that target eukaryotic parasites |
| 04/10/2001 | US6214584 Nucleotide sequence which encodes polypeptide associated with immunocompetence; for use in the treatment and prevent of tumors, viral diseases, bacterial infections and autoimmune diseases |
| 04/10/2001 | US6214583 HCV genomic sequences for diagnostics and therapeutics |
| 04/10/2001 | US6214581 Nucleic acids encoding a functional human purinoreceptor P2X3 and P2X6, and methods of production and use thereof |
| 04/10/2001 | US6214580 Nucleotide sequences coding binding protein associated with apoptosis; for detecting modulators of apoptosis; for treating cancers, sepsis, cachexia, autoimmune and viral diseases, inflammation, nervous system and liver disorders |
| 04/10/2001 | US6214578 Nucleotide sequences for the transcription of exogenous genes; insert nucleotide sequences into mutiple sites, detect preferential transcripts |
| 04/10/2001 | US6214572 Programmed cell death and ICH-3 |
| 04/10/2001 | US6214569 Detecting therapeutic agents for treatment of nervous system disorders; incubate modulators and test compound, monitor reduction in the formation of peptide filaments in cells |
| 04/10/2001 | US6214568 Monoclonal antibodies of isotype IgG which bind specifically to glutamate decarboxylase, and uses thereof |
| 04/10/2001 | US6214565 Assay for disease related conformation of a protein and isolating same |
| 04/10/2001 | US6214562 Transcriptionally regualted G protein-coupled receptor |
| 04/10/2001 | US6214559 Methods of identifying inhibitors of binding of IL-13 to the IL-13 receptor chain |
| 04/10/2001 | US6214553 Libraries of protein encoding RNA-protein fusions |
| 04/10/2001 | US6214547 For secreting polypeptides in yeast |
| 04/10/2001 | US6214544 Method to identify tumor suppressor genes |
| 04/10/2001 | US6214543 DNA molecule encoding for cellular uptake of Mycobacterium tuberculosis and uses thereof |
| 04/10/2001 | US6214541 Monitoring the activity of preferential immunoglobulins; incubate bound human papilloma virus with body fluid and preferential immunoglobulins, observe signal from bound proteins |
| 04/10/2001 | US6214540 Chemokines that inhibit immunodeficiency virus infection and methods based thereon |
| 04/10/2001 | US6214539 Synthetic antigen the detection of aids-related disease |
| 04/10/2001 | US6214537 Amino acid sequences for the detection of preferential viral diseases |
| 04/10/2001 | US6214358 Isolated bermuda grass pollen protein allergens or antigenic or allergenic fragments thereof, useful for diagnosing and treating sensitivity in an individual to bermuda grass pollen allergens |
| 04/10/2001 | US6214356 Administering to the mammal a preparation comprising a portion of the amino acid sequence of mature adenylate cyclase of a second bordetella species; respiratory diseases, whooping cough |
| 04/10/2001 | US6214355 DbpA compositions |
| 04/10/2001 | US6214353 Malaria recombinant poxvirus vaccine |
| 04/10/2001 | US6214348 Administering to the mammal a polypeptide comprising seq id no:2 in an amount sufficient to induce an immunological response to produce antibodies to seq id no:2 |
| 04/10/2001 | US6214347 Multideterminant peptides that elicit helper T-lymphocyte, cytotoxic T lymphocyte and neutralizing antibody responses against HIV-1 |
| 04/10/2001 | US6214346 Bactericides |
| 04/10/2001 | US6214345 Lysosomal enzyme-cleavable antitumor drug conjugates |
| 04/10/2001 | US6214341 Percutaneously administering to patient an effective amount of human clostridium difficile toxin-neutralizing polyclonal immune globulin obtained from a human subject immunized with a clostridium difficile toxin or toxoid |
| 04/10/2001 | US6214340 Physiologically active substance sulphostin, process for producing the same, and use thereof |
| 04/10/2001 | US6214338 Comprising platelets and platelet releasate, from 5 to 400 mg/ml of fibrinogen, and a physiologically acceptable carrier comprising water and physiologically acceptable inorganic and organic ions at a physiologically acceptable concentration |
| 04/10/2001 | US6214333 Vasoprotective recombinant adenovirus vector containing a human TFPI gene |
| 04/10/2001 | US6214316 Comprising cyclic peptide derivatives; kit for preparing a radiopharmaceutical preparation, comprising a sealed vial containing a predetermined quantity of the peptide |
| 04/10/2001 | CA2191858C Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy |
| 04/10/2001 | CA2163151C Humanized and chimeric monoclonal antibodies that recognized epidermal growth factor receptor (egf-r). use diagnostic and therapeutic |
| 04/10/2001 | CA2152075C Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease |
| 04/10/2001 | CA2130436C Cloning and expression of humanized monoclonal antibodies against human interleukin-4 |
| 04/10/2001 | CA2123787C Method of treating non-streptococcal bacterial infections |
| 04/10/2001 | CA2076901C Kainate-binding, human cns receptors of the eaa2 family |
| 04/10/2001 | CA2074089C Extracellular segments of human e immunoglobulin anchoring peptides and antibodies specific therefor |
| 04/10/2001 | CA2070647C Use of an anticoagulant as a diagnostic agent |
| 04/10/2001 | CA2067233C Fibronectin binding peptide |
| 04/10/2001 | CA2020598C Inducible expression vectors |
| 04/10/2001 | CA2015769C Production of biologically active polypeptides through treatment with an exogenous peptide sequence |
| 04/10/2001 | CA1341212C Osteoinductive factors |
| 04/05/2001 | WO2001023882A1 DETECTION OF POLYPEPTIDE FRAGMENTS AND MODIFIED FORMS OF α1-ANTITRYPSIN FOR EARLY DIAGNOSIS OF INFLAMMATION |
| 04/05/2001 | WO2001023615A1 Anti-aging nucleic acid and protein targets |
| 04/05/2001 | WO2001023602A1 Method for determining and modifying protein/peptide solubility |
| 04/05/2001 | WO2001023599A1 Streptococcus pneumoniae ykqc |
| 04/05/2001 | WO2001023598A1 41 human secreted proteins |
| 04/05/2001 | WO2001023597A2 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus |
| 04/05/2001 | WO2001023594A2 Enhanced stress tolerance in maize via manipulation of cell cycle regulatory genes |
| 04/05/2001 | WO2001023592A2 Methods for making recombinant proteins using apoptosis inhibitors |
| 04/05/2001 | WO2001023577A2 Hybrid or chimeric polynucleotides, proteins, and compositions comprising hepatitis b virus sequences |
| 04/05/2001 | WO2001023575A2 Wuschel (wus) gene homologs |
| 04/05/2001 | WO2001023574A1 Molecular markers of the pre-germination stage of plant seeds and use thereof in elisa tests |
| 04/05/2001 | WO2001023572A2 Polynucleotides and polypeptides encoded thereby |
| 04/05/2001 | WO2001023571A1 Methods and compositions relating to sodium channel beta1a subunits |
| 04/05/2001 | WO2001023570A2 Methods and compositions relating to sodium channel beta-1a subunits |
| 04/05/2001 | WO2001023569A1 Cytokine receptor materials and methods |
| 04/05/2001 | WO2001023568A2 Members of the iap gene family |
| 04/05/2001 | WO2001023567A1 Membrane-bound protein-60 |
| 04/05/2001 | WO2001023566A1 Novel human organic anion transporter-like proteins and polynucleotides encoding the same |
| 04/05/2001 | WO2001023565A1 P-glycoproteins from macaca fascicularis and uses thereof |
| 04/05/2001 | WO2001023564A1 Secreted factors |
| 04/05/2001 | WO2001023563A2 Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors |
| 04/05/2001 | WO2001023562A2 Osteoprotegerin regulatory region |
| 04/05/2001 | WO2001023561A2 Novel polynucleotides encoding proteins containing thrombospondin type 1 repeats |